Intimation under Regulation 30 of SEBI(LODR) Regulations 2025.
Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs &Pharmaceuticals Ltd Held On Today I.E. Tuesday, 06Th May, 2025.
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
- Announcement under Regulation 30 (LODR)-Resignation of Managing Director
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 30 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Mar 27 2025
Later from Welcure Drugs and Pharmaceuticals
- Appointment of Company Secretary and Compliance Officer
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 06 2025
- Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of TheSecurities And Exchange Board Of India (Listing Obligations And Disclosure Requirements),Regulations, 2015.
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 09 2025
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals